{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:05:15Z","timestamp":1791198315742,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ejca.2005.08.041","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T19:07:22Z","timestamp":1137697642000},"page":"534-541","source":"Crossref","is-referenced-by-count":30,"title":["Survival in France after childhood acute leukaemia and non-Hodgkin\u2019s lymphoma (1990\u20132000)"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Goubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Auclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Auvrignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Patte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"H\u00e9mon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejca.2005.08.041_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/pbc.20148","article-title":"Cancer incidence among children in France, 1990\u20131999","volume":"43","author":"Desandes","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2005.08.041_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00008469-200404000-00002","article-title":"Incidence of childhood leukaemia and non-Hodgkin\u2019s lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990\u20131999","volume":"13","author":"Clavel","year":"2004","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"10.1016\/j.ejca.2005.08.041_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0959-8049(01)00045-4","article-title":"Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study","volume":"37","author":"Gatta","year":"2001","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2005.08.041_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2005.08.041_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/adc.64.5.657","article-title":"Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia","volume":"64","author":"Stiller","year":"1989","journal-title":"Arch Dis Child"},{"issue":"7","key":"10.1016\/j.ejca.2005.08.041_bib6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0959-8049(03)00064-9","article-title":"Population-based survival after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979 to 1998 \u2013 a report from the Childhood Cancer Registry of Piedmont (Italy)","volume":"39","author":"Pastore","year":"2003","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2005.08.041_bib7","first-page":"149","article-title":"Prognosis of acute lymphoblastic leukemia in children. Results of the French protocol FRALLE 93","volume":"185","author":"Schaison","year":"2001","journal-title":"Bull Acad Natl Med"},{"issue":"3","key":"10.1016\/j.ejca.2005.08.041_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2141.1998.00818.x","article-title":"Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group","volume":"102","author":"Donadieu","year":"1998","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.ejca.2005.08.041_bib9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","article-title":"Childhood leukemias","volume":"332","author":"Pui","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejca.2005.08.041_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukaemia \u2013 current status and future perspectives","volume":"2","author":"Pui","year":"2001","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2005.08.041_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/adc.70.3.219","article-title":"Survival from acute non-lymphocytic leukaemia, 1971\u201388: a population based study","volume":"70","author":"Stiller","year":"1994","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.ejca.2005.08.041_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0959-8049(01)00013-2","article-title":"Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978\u20131992: the EUROCARE study","volume":"37","author":"Coebergh","year":"2001","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2005.08.041_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/adc.80.4.311","article-title":"Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region","volume":"80","author":"Schillinger","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ejca.2005.08.041_bib14","unstructured":"Gloeckler Ries LA, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975\u20131995: National Cancer Institute."},{"issue":"6","key":"10.1016\/j.ejca.2005.08.041_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0959-8049(01)00002-8","article-title":"Survival of childhood lymphomas in Europe, 1978\u20131992: a report from the EUROCARE study","volume":"37","author":"Pastore","year":"2001","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1016\/j.ejca.2005.08.041_bib16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","article-title":"Non-Hodgkin\u2019s lymphoma in childhood","volume":"334","author":"Sandlund","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2005.08.041_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0959-8049(97)10142-3","article-title":"Non-Hodgkin\u2019s lymphoma","volume":"34","author":"Patte","year":"1998","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2005.08.041_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/adc.81.3.202","article-title":"Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994","volume":"81","author":"Stiller","year":"1999","journal-title":"Arch Dis Child"},{"issue":"9451","key":"10.1016\/j.ejca.2005.08.041_bib19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(04)17550-8","article-title":"Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study","volume":"364","author":"Steliarova-Foucher","year":"2004","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.ejca.2005.08.041_bib20","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d\u2019Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejca.2005.08.041_bib21","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1182\/blood.V98.6.1714","article-title":"Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia","volume":"98","author":"Webb","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejca.2005.08.041_bib22","first-page":"3591","article-title":"CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology","volume":"92","author":"Brugieres","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2005.08.041_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.1999.01304.x","article-title":"Definition of a standard-risk group in children with AML","volume":"104","author":"Creutzig","year":"1999","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ejca.2005.08.041_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1999.17.3.818","article-title":"Sex differences in prognosis for children with acute lymphoblastic leukemia","volume":"17","author":"Pui","year":"1999","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2005.08.041_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1200\/JCO.1987.5.7.1026","article-title":"Prognostic factors in childhood acute myelogenous leukemia","volume":"5","author":"Grier","year":"1987","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2005.08.041_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.leu.2402390","article-title":"Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children\u2019s Cancer Group Study 213","volume":"16","author":"Wells","year":"2002","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ejca.2005.08.041_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1365-2141.1996.d01-1761.x","volume":"94","author":"Lie","year":"1996","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.ejca.2005.08.041_bib28","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2401555","article-title":"Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study","volume":"13","author":"Pullen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.08.041_bib29","unstructured":"Auvrignon A, Baruchel A, Behar C, et al. Protocole multicentrique de traitement des leuc\u00e9mies aigu\u00ebs my\u00e9loblastique de l\u2019enfant et de l\u2019adolescent. Etude randomis\u00e9e d\u2019un traitement d\u2019entretien par un interleukine 2; 2003 [In France]."},{"issue":"1","key":"10.1016\/j.ejca.2005.08.041_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/adc.81.1.32","article-title":"Improved outcome of acute myeloid leukaemia in Down\u2019s syndrome","volume":"81","author":"Craze","year":"1999","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.ejca.2005.08.041_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pbc.20207","article-title":"Acute myeloid leukemia and Down syndrome evolution of modern therapy \u2013 state of the art review","volume":"44","author":"Gamis","year":"2005","journal-title":"Pediatr Blood Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905010609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905010609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T03:54:19Z","timestamp":1547870059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804905010609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0959804905010609"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.08.041","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}